In the study by Chappell et al., antithrombin treatment has been found to alleviate glycocalyx destruction, suppress shedding of syndecan-1 and heparan sulfate, and block vessel leakage caused by inflammation due to infused TNF-α or ischemia in guinea pig hearts [198,207]. The gene discussed is SDC1; the disease is ischemia.